M2Bio Sciences

M2Bio Sciences is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and mental health treatment research. M2Bio's mission is to advance botanical medicine by deploying best-practice science and medicine, clinical research, and emerging technologies. As one of the few companies in the world, M2Bio is actively researching the remarkable mushroom compound psilocybin by funding research at the University of Pretoria in South Africa. This exploratory research aims to discover new indications for medical conditions such as depression, inflammation, and substance addiction.